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A B S T R A C T
Purpose: As pharmacists play an important role in managing antiepileptic drug (AED) therapy, they
should be aware of different aspects of the treatment. Our aim was to evaluate pharmacists’ knowledge
of the pharmacological treatment of epilepsy, and their recommendations under hypothetical situations,
through a written questionnaire.
Methods: The questionnaire included 22 questions divided into three sections: demographic data (eight
questions), knowledge of speciﬁc aspects of AED therapy (true/false; four questions), and actions taken
in theoretical situations involving AED therapy (multiple choice; ten questions). The questionnaire was
distributed to pharmacists practicing in Israel and working in pharmacies and/or participating in
professional meetings and continued education programs.
Results: One hundred and twenty one pharmacists completed the questionnaire (response rate 19%). The
mean overall score was 48  15% correct answers. Most pharmacists were aware of the need to continue AED
treatment during pregnancy, the risk of generic switches, and the need to call the physician for loss of seizure
control (92%, 89% and 81% of responders, respectively). Twelve percent identiﬁed correctly all three situations in
which the clinicians should be contacted urgently, and 27% did not identify any of them. The total score was
related to the academic degree (PharmD vs. other) and to the duration since training completion.
Conclusion: Pharmacists were knowledgeable regarding some aspects of care of people with epilepsy.
However, our study, as in previous studies among health care professionals, identiﬁed some gaps in
knowledge. These ﬁndings indicate the need for better education of pharmacists regarding epilepsy and
its treatment.
 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Antiepileptic drugs (AEDs) are the essence of epilepsy
treatment, and 70-80% of adults with new onset epilepsy may
become seizure free with optimal AED therapy [1,2]. However, up* Corresponding author at: Institute for Drug Research, Room 613, School of
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[2,3] and 20–30% are drug resistant [4,5]. In addition, sometimes
more than one AED is required in order to control seizures, and
patients may be treated for concomitant diseases. This may lead to
drug–drug interactions [6,7]. The medical treatment of people with
epilepsy (PWE) is even further complicated by the fact that certain
subpopulations, such as women of childbearing age and patients of
Asian origin, present very speciﬁc considerations [8,9]. Accordingly,
a survey among PWE attending a tertiary referral epilepsy
outpatient clinic indicated that patients know more about epilepsy
in general than about their own condition [10]. All of these issues
may have a substantial inﬂuence on the control of seizures and on
patients’ quality of life, and therefore should be well recognized by
healthcare providers.served.
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PWE. Pharmacists have the opportunity to prevent drug-related
untoward occurrences, by representing the last barrier between
the patient and the drug. They can verify that the dose is
reasonable; warn prescribing physicians regarding potential drug–
drug interactions; and give patients essential drug information,
such as information regarding possible drug-related adverse
events [11–13]. Moreover, a survey among PWE indicated that
patients most commonly consult their pharmacist with regard to
drug interactions and adverse effect information [13]. This clearly
indicates the need for pharmacists to be knowledgeable regarding
epilepsy and its treatment. However, previous research indicated
that pharmacists’ acquaintance with speciﬁc areas of AED
prescription and utilization, i.e., women’s health [14] and generic
drug substitution [15], is lacking. These ﬁndings are along the same
line of evidence with data showing that even neurologists treating
epilepsy patients are not continuously updated with regard to AED
treatment [16].
The aim of this study was to evaluate pharmacists’ knowledge
regarding the use of AEDs, and their recommendations based on
this knowledge, through a written questionnaire. We were also
interested in identifying the impact of demographic variables on
pharmacists’ knowledge. The survey included pharmacists with
various levels of formal education and experience.
2. Methods
2.1. Ethics approval
The study protocol was approved and a waiver of consent
granted by the Institutional Review Board at the Hadassah-Hebrew
University Medical Center, Protocol No. 0486-13-HMO. The
questionnaire was ﬁlled anonymously and data were saved
without identifying details.
2.2. Participants
Participants in the study were licensed pharmacists, certiﬁed by
the Israeli Ministry of Health, who understand and speak Hebrew
and who were willing to answer a 22-item questionnaire.
Pharmacists who already completed the questionnaire in another
setting, pharmacist assistants, undergraduate students and trai-
nees who were not licensed at the time of the study were excluded.
Enrollment began on December 2013 and ended on June 2014.
2.3. The questionnaire
The questionnaire (supplementary information) included three
types of questions: A. Questions aimed to collect demographic
data; B. A true/false format of questions assessing AED-related
knowledge (n = 4); C. A single-response, multiple-choice format of
questions listing pharmacists’ possible actions in theoretical
situations involving AED therapy (n = 10). Parts B and C included
questions regarding emergency situations (n = 3), women’s health
(n = 3) and drug–drug interactions (n = 5), along with miscella-
neous topics (generic switches, lamotrigine’s initial dose, and
interpretation of valproic acid blood concentration; n = 3). Two
questions were included in similar studies that had taken place in
the United States [14,15,17]. Parts B and C questions were followed
by sections entitled ‘‘comments’’, each including two empty lines.
The initial version of the questionnaire was composed by three
of the authors of this work (YR, DE, SE) and was changed to the ﬁnal
form after revision for content validity and clarity by two
epileptologists (MYN and IB, former and current presidents of
the Israeli Chapter of the International League Against Epilepsy –
ILAE) and two PharmD currently practicing pharmacists (SG andSR). For validating that the subjects do not provide arbitrary
answers, one difﬁcult true/false question (urinary retention is an
adverse effect that may require the use of a catheter in patients
that are taking ruﬁnamide – correct answer: false – this being an
adverse event of retigabine) was presented in part B of the
questionnaire and was not included in the ﬁnal analysis. As
expected, only 21 participants (10%) gave a correct answer to this
question and 98 (81%) noted that they did not know the correct
answer. Following comments from the participants, the two
answers suggesting not dispensing the drugs and calling the
physician in response to each of the three emergency situations in
part B (three questions in total) were both considered correct (see
supplementary information).
2.4. Data collection
Following permission granted from the relevant administrative
personnel in charge, the questionnaire was presented to pharma-
cists in one of the following four settings: (1) Pharmacists working
in drugstores of Super-Pharm, the largest drugstore chain in Israel,
were approached in 9 out of 12 stores in Jerusalem during working
hours. The questionnaire forms were collected 2–7 days later; (2)
Maccabi Health Maintenance Organization’s (HMO) pharmacists
were approached, during a training course unrelated to epilepsy or
AEDs. Pharmacists were allowed 15 min to complete the ques-
tionnaire; (3) The forms were distributed to pharmacists
participating in one of two semiannual meetings of the Pharma-
ceutical Society of Israel (PSI). The entire meeting day was allotted
to completing the questionnaire; (4) The forms were distributed to
pharmacists participating in the PharmD Program of the Hebrew
University School of Pharmacy. Fifteen minutes were allotted to
complete the questionnaire.
Pharmacists were not supposed to consult any information
resources when they were taking the quiz, and those who
answered the quiz in small classes (pharmacists participating in
the PharmD program or Maccabi’s pharmacists) were not able to
do so. We could not validate that the other pharmacists did not use
information resources. No ﬁnancial incentives were offered to
encourage participation. However, a document containing detailed
answers to the study questions was prepared and distributed
among members of the organizations participating in the study.
2.5. Data analysis
The ﬁnal score was expressed as the percentage of correct
answers of each pharmacist. The option ‘‘I don’t know’’ was
considered a separate category, and included in the estimation of
the score per question as a wrong answer. Responders were
grouped into one of two categories of duration since graduation
from training (ﬁve years or less and longer than ﬁve years) and of
countries in which the BScPharm degree was obtained (Israel,
other). Descriptive statistics were obtained for the various
variables. Response patterns were evaluated using the two-tailed
Mann–Whitney test, the Kruskal–Wallis test, and the Pearson
correlation (GraphPad Instat 3, La Jolla, CA, USA), as appropriate.
The results are reported as mean  standard deviation (SD), unless
otherwise indicated. A p-value 0.05 was considered signiﬁcant.
3. Results
A total of 121 pharmacists completed the questionnaire. These
included 17 pharmacists out of the 59 pharmacists working in
2014 in the nine approached Super-Pharm stores in Jerusalem
(29%), all 29 pharmacists who participated in Maccabi HMO’s
training class, 65 out of the 535 participants of the PSI conferences
(5.4% of participants), and 10 PharmD students who attended a
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elsewhere (100% of eligible participants). The total response rate
was 19%.
The compiled demographic data are presented in Table 1. Most
responders were women (72%) and studied pharmacy in Israel
(84%). Thirty seven percent completed only a BSc in pharmacy. The
remainder of pharmacists participating in this study had additional
degrees, including one quarter of all participants who completed a
PharmD degree. The majority (63%) estimated that they encounter
ten or less PWE each month, and only one ﬁfth underwent AED-
related training during the year preceding the survey.
The total mean score was 48  15% (Fig. 1). Overall, the true/false
questions were relatively easier to address, compared with the
multiple choice questions (76  22% vs. 45  17%, respectively;Table 1
Characteristics of study participants.
Parameter No. (%)
Total participants 121
Age (years) [mean  SD, (range)] 35.2  9.1 (24–67)
Sex
Men 33 (28%)
Women 86 (72%)
Not indicated 2
Country of academic studies
Israel 102 (84%)
Othera 19 (16%)
Highest academic degreeb
BSc or equivalent 39 (37%)
MSc or equivalent 26 (25%)
PhD 6 (6%)
PharmD 27 (26%)
Otherc 6 (6%)
Not indicated 17
Duration since graduation (years)
0–2 24 (20%)
3–5 28 (24%)
6–10 26 (22%)
11–20 28 (24%)
>20 13 (11%)
Not responded 2
Occupation
Community/retail pharmacy, full time 46 (38%)
Community/retail pharmacy, part time 32 (26%)
Hospital, full timed 19 (16%)
Othere 24 (20%)
Estimated number of PWE/month
0 23 (21%)
1–5 29 (26%)
6–10 18 (16%)
11–20 21 (19%)
>20 20 (18%)
Not indicated 10
AED training over the past year
None 95 (79%)
Academic 7 (6%)
PSI 5 (4%)
Otherf 13 (11%)
Not indicated 1
Setting
PSI 65 (54%)
Maccabi HMO 29 (24%)
Super-Pharm 17 (14%)
PharmD seminar 10 (8%)
Results are expressed as mean  SD (range), unless otherwise indicated.
a Brazil, England, France, Georgia, Hungary, Italy, Jordan, Russia.
b No pharmacists with a double PharmD/PhD participated in the survey. A
PharmD degree was considered higher than other academic degrees, with the
exception of PhD.
c Masters in public health (MPH).
d Almost all pharmacist positions in Israeli hospitals are full time. Exceptions
were counted as ‘‘other’’.
e Retirement home, HMO Headquarters ofﬁces, hospital + retail pharmacy, part
time at a hospital.
f Academic + other (not speciﬁed). PSI, Pharmaceutical Society of Israel.
Fig. 1. Total scores across all responders. CBZ, carbamazepine; DDI, drug–drug
interaction; LEV, levetiracetam; LTG, lamotrigine; OCs, oral contraceptives; PHT,
phenytoin; PWE, people with epilepsy; TPM, topiramate; VPA, valproic acid.p < 0.01). Pharmacists obtained the highest correct scores on the
true/false statements inquiring about the use of AEDs during pregnancy
and the outcome of generic switches (93% and 89%, respectively). Only
13  38% were familiar with the prescription issues related to valproic
acid–lamotrigine interaction. The scores of the different topics were
similar. Statistical analysis to assess variation among the topics was not
conducted due to the small number of questions representing each
topic. Across all questions and all study participants, the option ‘‘I don’t
know (f)’’ was selected in 5.0% of cases.
A more detailed analysis of the emergency-related questions
revealed that the majority of pharmacists would call the
prescribing physician immediately for levetiracetam-related
suicidal thoughts and for acute seizure aggravation. However, at
least 25%, 13% and 7% of responders would not identify
lamotrigine-induced rash, suicidal thoughts and seizure aggrava-
tion, respectively, as conditions that require immediate action
(Fig. 2A–C). Although some of the other pharmacists would call the
physician (16%, 13% and 7% for the ﬁrst, second and third situation,
respectively), they apparently would not understand the reason for
doing so and would still dispense the prescribed medication.
Twelve percent identiﬁed correctly all three situations in which the
clinicians should be contacted urgently, and 27% did not identify
any of them (Fig. 2D).
Pharmacists with a PharmD degree achieved better total scores
compared to those with other advanced degrees (e.g., MSc, PhD)
(60  13 vs. 50  14, respectively; p < 0.05), but not compared to
BScPharm graduates. Longer time since training completion was
associated with a lower total score (58  13% vs. 50  16% for the
pharmacists who were in practice 5 years or less and those with
longer time in practice, respectively; p < 0.05). In both cases, the
differences manifested particularly with regard to questions about
lamotrigine (Fig. 3 and data not shown). In contrast, the total score
was not affected by the setting in which the questionnaire was
distributed, gender, the country in which the BScPharm degree was
obtained (Israel vs. others); whether the pharmacist worked at a
community pharmacy, a hospital, or elsewhere, and whether they
underwent some form of training about AEDs over the year prior to
the survey (p > 0.05; data not shown). In addition, the total score was
not associated with the number of PWE seen monthly by the
pharmacist (p > 0.05) and did not correlate with the responders’ age
(r = 0.1596, p > 0.05).
Twenty six of the pharmacists included in this study added
comments under the ‘‘Comments’’ sections of the questionnaires.
Five comments related to lack of the responder’s knowledge, one
stated the need for more extensive education, seven referred to the
availability of data sources such as drug interactions databases that
Fig. 2. Distibution of answers to questions about emergency situation. Three of the multiple choice questions in the questionnaire presented emergency situations. Parts A–C
present the percent of pharmacists who selected each of the available responses (indicated in a box on the lower left corner). The corresponding translated question is listed
below the distribution charts. Only the response ‘‘Do not dispense, call the doctor’’ was considered correct. (D) Percent of pharmacists who correctly identiﬁed none, one, two,
or all three emergency situations. DDIs, drug–drug interactions. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of
the article.)
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remainder of comments were related to the wording of the
statements or the answers.
4. Discussion
Pharmacists constitute a valuable source of information for
patients and prescribers [11–13]. As such, they should be familiar
with various aspects of treatment with AEDs, including drug–drug
interactions and women’s health, and be able to consult patients. It
has been shown that patients’ education about epilepsy results in
better seizure control, even in patients with a long history of
epilepsy [18], and that PWE desire to know much more about theirFig. 3. Percent of participants responding correctly to individual questions by type
of academic degree. Blue – BSc, orange – pharmD, gray – others. (For interpretation
of the references to color in this ﬁgure legend, the reader is referred to the web
version of the article.)disease and medications [19]. Unfortunately, epilepsy patients’
knowledge regarding their illness and its treatment is unsatisfac-
tory [12,18]. Furthermore, pharmacists can be the ﬁrst to recognize
conditions in which the physician should be contacted as soon as
possible. Yet, our study found signiﬁcant knowledge gaps among
pharmacists, including those who see PWE frequently; the mean
score of surveyed pharmacists was only 48%. Several responders
checked the ‘‘I don’t know’’ option or commented that they don’t
know the answer, implying that they were able to admit that they
have gaps of knowledge. This ability, with regard to neurologists,
was previously described by Roberts et al. as the ﬁrst step towards
addressing changes in practice [20].
Remarkably, certain high-awareness areas were identiﬁed.
Most pharmacists were aware of the risk of generic switches, and
the need to call the physician for loss of seizure control (90% and
81% of pharmacists, respectively). However, although 92% of the
participants acknowledged that women should continue AEDs
during pregnancy, only one ﬁfth would dispense valproic acid to a
pregnant woman. Also, less than 20% of the pharmacists knew that
the physician should be consulted urgently for lamotrigine-
induced rash, and only 34% identiﬁed the interaction between
phenytoin and tacrolimus. Of note, several responders commented
that they rely on computer drug-interaction applications at work
and hence the lack of knowledge should not affect their ability to
consult patients with regard to drug interactions. As expected, the
responders addressed better the true/false compared to multiple
choice questions, both because of the more limited choice options
and the relative clarity of the true/false statements that did not
involve situations which could potentially be interpreted in several
ways.
The duration since professional training completion and a
PharmD degree were the only predictors associated with overall
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the absence of updated knowledge about epilepsy and AEDs. In
addition, there was a partial overlap between shorter duration
since graduation and a PharmD degree. The majority of Israeli
pharmacists with a PharmD degree graduated over the past four
years from a single school of pharmacy, in which personalized
medicine has been an important component of the curriculum.
Thus, for both comparisons, the greatest gaps were detected in
questions related to lamotrigine-induced Stevens-Johnson syn-
drome/toxic epidermal necrolysis. Interestingly, there was no
relationship between larger numbers of PWE seen each month and
scores. This is in contrast to previous works assessing the
knowledge of health care professionals [14,21], and may be
explained by reliance on computerized resources and minimal
time for interacting with patients and actually consulting them.
The setting in which the questionnaire was presented, and
therefore the time allowed for their completion and the percentage
of practicing pharmacists among the participants, did not affect the
scores. Intriguingly, recent training about epilepsy or AEDs was not
shown to increase performance in completing the questionnaire,
although the type of training was not detailed. It is necessary to
consider the optimal type of education that may efﬁciently
improve pharmacists’ knowledge and actions.
The total score of our questionnaire appears similar or slightly
lower than those reported in previous studies among health
professionals, which also reported severe knowledge deﬁcits
[14,15,17,20,22]. For instance, in surveys among pharmacists
and neurologists or neurology residents regarding women’s issues,
the overall average correct scores were 60.3% [14] and 50% [20],
respectively. For true/false questions that were included in
previous studies, the scores of our survey were consistent with
those reported before. For example, 92% of responders in our study
knew that AEDs should not be stopped in women with epilepsy
when they become pregnant, and 90% were aware of the issues
associated with generic switches, compared to 87% of pharmacists
surveyed in previously published studies, for both questions
[14,15]. Among attendees of the American College of Physicians
2003 Annual Meeting, only 75% realized that pregnant women
with epilepsy should remain on medication [17]. Based on the
better scores obtained for the true/false compared to the multiple
choice questions, it seems that the difﬁculty of the multiple choice
part of questionnaire was at a higher level than previous
questionnaires in terms of both speciﬁcity of required knowledge
and the choices themselves. However, these questions have greater
relevance to actual practice and they may better reﬂect the effect of
pharmacists’ knowledge on the management of PWE.
The major limitations of our study are related to potential
selection bias, to the partial validation of the questionnaire, and to
the potential for generalization of our results to other countries.
The majority of our participants were pharmacists who attend
meetings and training courses, who may be more knowledgeable
than other pharmacists. Among those who attended the PSI
meetings, low response rate may further increase the bias towards
those who may be willing to answer the questionnaire because
they felt more comfortable with their degree of knowledge. Yet,
participants (including clinical pharmacists) pointed out that the
questionnaire was difﬁcult, and that the given options in the
situation-related multiple choice questions did not fully reﬂect the
possible options the pharmacist encounters at work as described
above. The limited response range also reﬂects another limitation
of the study: asking a clinical question via a multiple choice
question. Furthermore, the clinical pharmacists who validated the
questionnaire might not have been representative of all the
pharmacists who encounter such situations in community/retail
pharmacies. In addition, we assumed that the participants
completing the survey on their free time (the drugstorepharmacists) did not consult others or actively search for
information to answer the questions. However, no signiﬁcant
differences were found between the scores of participants in the
various settings of the study. Although this is a local survey,
performed in Israel, its scores were similar to the results presented
in studies from other countries, both generally and in regard to
speciﬁc questions [14,15,17,20]. Therefore, our work may be of
wider relevance to the healthcare professionals involved in the
management of PWE.
5. Conclusion
Pharmacists are in a key position to help PWE. Although they
are familiar with some areas related to AED treatment, there are
still gaps in knowledge. Clearly, educational interventions such as
continued education courses, local interactive workshops, and
practical sessions and web resources are required. These should be
followed by studies assessing their effectiveness in terms of
pharmacists’ knowledge and patient outcome.
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